ABOUT US

Precision Multiplex
Platform Creator

Key Events

These are the footsteps of BioSquare,
the company helping to improve human health and happiness

2023

  • 12

    Medical Immunofluorescence Measurement Device
    Manufacturing Declaration (QDITS™ Mini)

  • 10

    QuantumPACK™ Improvement Patent Registration (US)

  • 09

    QuantumPACK™ Improvement Patent Registration (US)

    QuantumPACK™ Improvement Patent Registration (JP)

  • 08

    QuantumPACK™ Improvement Patent Registration (CN)

  • 06

    NanoPACK™ COVID-19 Ag Home MFDS Manufacturing approval (Class 3)

  • 04

    QuantumPACK™ EASY COVID-19 Ag MFDS Manufacturing approval (Class 3)

  • 01

    NanoPACK™ COVID-19 Ag MFDS Manufacturing approval (Class 3)

2022

  • 11

    Selected for the "Baby Unicorn 200" growth program

  • 10

    QuantumPACK™ Improvement Patent Registration (JP)

  • 08

    QuantumPACK™ Improvement Patent Registration (KR)

  • 06

    QuantumPACK™ Improvement Patent Registration (EU 9 countries)

  • 05

    QuantumPACK™ Easy Influenza A+B CE Marked

  • 04

    QuantumPACK™ Improvement Patent Registration (JP)

    QuantumPACK™ COVID-19 Ag CE Marked

    NanoPACK™ COVID-19 Ag CE Marked

    ISO 13485:2016 Certified

  • 03

    QuantumPACK™ EASY Influenza A+B MFDS Manufacturing approval (Class 3)

  • 02

    GMP Certification (Dongtan factory, Class 3)

2021

  • 09

    QuantumPACK™ Improvement Patent Registration (KR)

  • 08

    QuantumPACK™ Improvement Patent Registration (KR)

  • 06

    Medical Immunofluorescence Measurement Device
    Manufacturing Declaration (QDITS™)

  • 01

    Series A Investment Round Closed (7.5 B KRW)

    Purchased Dongtan site and moved HQ
    (Gyeonggido Hwaseongsi Samsung1-ro 4-gil 15)

2020

  • 12

    Clinical trial GMP certification (Class 3))

  • 06

    RIGHT Fund Product Development Award (Leishmaniasis Diagnostics)

    Selected as Post-TIPS 1st round startup

  • 03

    E-credible Investment-grade technology evaluation TI3 (TCB)

2019

  • 12

    Medical device manufacturing license application

  • 08

    QuantumPACK™ Improvement Patent Registration (KR)

  • 03

    QuantumPACK™ Improvement Patent Registration (KR)

2018

  • 10

    Selected for KOICA Creative Technology Solution (CTS) program
    (LIC/LMIC problem solving program)

    Seongnam factory registration (Seongnamsi Sangdaewondong)

  • 04

    Joint Venture agreement with CapitalBio group
    (subsidiary of Tsinghua Holdings)

    Selected as the 1st Frontier Venture company by KIBO

  • 01

    Company R&D Center approval Moved HQ
    (Pangyo Institut Pastuer Korea, 3rd floor)

2017

  • 12

    Selected for TIPS program November startup team

    Selected for Bio Core Facility establishment project
    (Ministry of Science, Technology, Information and Communication)

  • 10

    Successfully raised pre-series A (2 B KRW)

    Received KIBO guarantee

  • 09

    Successfully raised seed round (200 M KRW)

  • 08

    Exclusive license for QuantumPACK™ patents (Seoul National University)

  • 06

    Company established